BOSTON & MONTREAL–(BUSINESS WIRE)–enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced that management will participate in the following investor conferences: UBS Global Biopharma Conference 2026 Date: Monday, November 16, 2026 Time: 3:20 p.m. GMT / 10:20 a.m. ET Format: Fireside Chat Jefferies Global Healthcare Conference in London Date: Thursday, November 19, 2026 Time: 10:30 a.m. GMT / 5:30 a.m. ET Format:

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.